Oral propranolol for treatment of periocular infantile hemangiomas

Archives of Ophthalmology

Volumn 129, Issue 7, 2011, Pages 899-903

  Missoi, Tara G ^a   Lueder, Gregg T ^b   Gilbertson, Kenneth ^b   Bayliss, Susan J ^b  

^a University of Missouri   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPLEGIC AGENT; PROPRANOLOL;

AMBLYOPIA; ARTICLE; ASTIGMATISM; BRADYCARDIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; EYE EXAMINATION; HEMANGIOMA; HUMAN; INFANT; OUTPATIENT CARE; PARTICIPANT OBSERVATION; PATIENT MONITORING; PHOTOGRAPHY; PRIORITY JOURNAL; SURFACE PROPERTY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VISION TEST; VISUAL ACUITY; VISUAL STIMULATION;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; CHILD, PRESCHOOL; EYELID NEOPLASMS; FEMALE; HEMANGIOMA, CAPILLARY; HUMANS; INFANT; MALE; ORBITAL NEOPLASMS; PROPRANOLOL; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960161403     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.40     Document Type: Article

References (14)

1. Bruckner AL, Frieden IJ. Infantile hemangiomas. J Am Acad Dermatol. 2006;55 (4):671-682. (Pubitemid 44436645)
2. Wasserman BN, Medow NB, Homa-Palladino M, Hoehn ME. Treatment of periocular capillary hemangiomas. J AAPOS. 2004;8(2):175-181. (Pubitemid 38481769)
3. Schwartz SR, Kodsi SR, Blei F, Ceisler E, Steele M, Furlan L. Treatment of capillary hemangiomas causing refractive and occlusional amblyopia. J AAPOS. 2007; 11(6):577-583. (Pubitemid 350251248)
4. Nguyen J, Fay A. Pharmacologic therapy for periocular infantile hemangiomas: a review of the literature. Semin Ophthalmol. 2009;24(3):178-184.
5. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358 (24):2649-2651. (Pubitemid 351831393)
6. American Academy of Ophthalmology Pediatric Ophthalmology/Strabismus Panel. Preferred Practice Pattern Guidelines: Pediatric Eye Evaluations: Screening and Comprehensive Ophthalmic Evaluation. San Francisco, CA: American Academy of Ophthalmology; 2007.
7. Taban M, Goldberg RA. Propranolol for orbital hemangioma. Ophthalmology. 2010;117(1):195.
8. Drugsite Trust. Propranolol dosage. Drugs.com Web site. http://www.drugs.com/dosage/propranolol.html. Accessed April 6, 2010.
9. Frieden IJ, Drolet BA. Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol. 2009;26(5):642-644.
10. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2009;26(5):610-614.
11. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med. 2008;359(26):2846-2847.
12. Bayliss SJ, Berk DR, Van Hare GF, et al. Re: propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2010;27(3):319-320.
13. Guo S, Ni N. Topical treatment for capillary hemangioma of the eyelid using β-blocker solution. Arch Ophthalmol. 2010;128(2):255-256.
14. Rosca TI, Pop MI, Curca M, et al. Vascular tumors in the orbit - capillary and cavernous hemangiomas. Ann Diagn Pathol. 2006;10(1):13-19. (Pubitemid 43088800)